Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $2.1 million.

  • Biodesix's Interest Expenses rose 161.69% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year decrease of 1614.04%. This contributed to the annual value of $8.3 million for FY2024, which is 1340.18% down from last year.
  • Per Biodesix's latest filing, its Interest Expenses stood at $2.1 million for Q3 2025, which was up 161.69% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Interest Expenses registered a high of $3.0 million during Q3 2022, and its lowest value of $651000.0 during Q1 2021.
  • Its 5-year average for Interest Expenses is $1.9 million, with a median of $1.9 million in 2024.
  • Data for Biodesix's Interest Expenses shows a peak YoY increase of 11219.86% (in 2021) and a maximum YoY decrease of 7072.56% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Biodesix's Interest Expenses stood at $1.5 million in 2021, then skyrocketed by 70.45% to $2.6 million in 2022, then fell by 8.67% to $2.3 million in 2023, then decreased by 24.77% to $1.8 million in 2024, then grew by 18.38% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $1.9 million for Q2 2025, and $1.7 million during Q1 2025.